Literature DB >> 20728288

Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.

A Karow1, J Reimer, I Schäfer, M Krausz, C Haasen, U Verthein.   

Abstract

BACKGROUND: There is increasing evidence that health-related quality of life (HRQOL) is associated with a successful treatment and better outcome in opioid addiction. The aim of the present study was the longitudinal investigation of HRQOL in patients with severe opioid dependence, who were randomly assigned to four groups of medical and psychosocial treatment: heroin (diacetylmorphine) versus methadone and case management (CM) versus psychoeducation (PSE) respectively.
METHODS: HRQOL (MSQoL) and physical health (OTI) were investigated in 938 subjects, who participated in the German multi-centre study examining the effects of heroin-assisted treatment in patients with severe opioid dependence. Data for the present analysis were taken from baseline and 12-month follow up.
RESULTS: Under both forms of maintenance and psychosocial treatment HRQOL improved significantly during the observation period. HRQOL improvement under maintenance with heroin exceeded improvement under methadone, especially with regard to subjective physical health. HRQOL improvement was significantly associated with better expert-rated physical health. Further analyses showed significant better improvement of HRQOL in subjects treated with PSE compared with CM.
CONCLUSIONS: The advantage of heroin with regard to the improvement of HRQOL may be partially explained by a better improvement of physical health under maintenance with heroin compared with methadone, which highlights the importance of a comprehensive model of health care for patients with severe opioid dependence. Future studies need to investigate the benefits of PSE for patients in maintenance therapy.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20728288     DOI: 10.1016/j.drugalcdep.2010.06.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  23 in total

Review 1.  [Case management studies for individuals 65 years and older in Germany: Systematic review of the currently published state of research].

Authors:  Beate Gaertner; Anna Herzog; Martin Holzhausen; Stefan Schmidt
Journal:  Z Gerontol Geriatr       Date:  2015-01-14       Impact factor: 1.281

2.  Intact responses to non-drug rewards in long-term opioid maintenance treatment.

Authors:  Marie Eikemo; Philipp P Lobmaier; Mads L Pedersen; Nikolaj Kunøe; Anna Maria Matziorinis; Siri Leknes; Monica Sarfi
Journal:  Neuropsychopharmacology       Date:  2019-03-31       Impact factor: 7.853

3.  Short term health-related quality of life improvement during opioid agonist treatment.

Authors:  B Nosyk; J W Bray; E Wittenberg; B Aden; A A Eggman; R D Weiss; J Potter; A Ang; Y-I Hser; W Ling; B R Schackman
Journal:  Drug Alcohol Depend       Date:  2015-10-25       Impact factor: 4.492

4.  Examining unidimensionality and improving reliability for the eight subscales of the SF-36 in opioid-dependent patients using Rasch analysis.

Authors:  Yu-Yu Hsiao; Ching-Lin Shih; Wan-Hui Yu; Cheng-Hsi Hsieh; Ching-Lin Hsieh
Journal:  Qual Life Res       Date:  2014-08-07       Impact factor: 4.147

5.  Characterizing the subjective, observer-rated, and physiological effects of hydromorphone relative to heroin in a human laboratory study.

Authors:  Kelly E Dunn; Bruna Brands; David C Marsh; George E Bigelow
Journal:  Psychopharmacology (Berl)       Date:  2017-12-21       Impact factor: 4.530

6.  Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention.

Authors:  Chethan Bachireddy; Alexander R Bazazi; Ravi Kavasery; Sumathi Govindasamy; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2011-01-12       Impact factor: 4.492

7.  Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline.

Authors:  Nadia Fairbairn; Josey Ross; Michael Trew; Karine Meador; Jeff Turnbull; Scott MacDonald; Eugenia Oviedo-Joekes; Bernard Le Foll; Marie-Ève Goyer; Michel Perreault; Christy Sutherland
Journal:  CMAJ       Date:  2019-09-23       Impact factor: 8.262

8.  Association of current and past opioid use disorders with health-related quality of life and employment among US adults.

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  Drug Alcohol Depend       Date:  2019-04-23       Impact factor: 4.492

Review 9.  Comparison of Treatment Options for Refractory Opioid Use Disorder in the United States and Canada: a Narrative Review.

Authors:  Simeon Kimmel; Paxton Bach; Alexander Y Walley
Journal:  J Gen Intern Med       Date:  2020-05-27       Impact factor: 5.128

Review 10.  Exercise as an adjunct treatment for opiate agonist treatment: review of the current research and implementation strategies.

Authors:  Jeremiah Weinstock; Heather K Wadeson; Jaci L VanHeest
Journal:  Subst Abus       Date:  2012       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.